开发用于脑损伤和缺血的生物标志物的进展
Diana Karimova1, Elham Rostami2, Vladimir N Chubarev3
1Functional Pharmacology and Neuroscience, Department of Surgical Sciences, Uppsala, University, Uppsala, Sweden.
Molecular biology reports
|July 13, 2024
概括
循环生物标志物为诊断急性脑损伤提供了一个有希望的替代方案,有可能改善患者的治疗结果. 本次审查强调了41种潜在的生物标志物,20种生物标志物已进入临床试验,用于早期检测.
科学领域:
- 神经学 神经学
- 生物化学 生物化学
- 生物标志物发现发现
背景情况:
- 获得性脑损伤需要快速诊断和治疗,通常依赖于昂贵的成像技术,如MRI和CT.
- 目前的诊断方法需要大量的基础设施和专业人员.
- 循环生物标志物为管理急性脑血管事件和降低死亡率提供了潜在的途径.
研究的目的:
- 审查大脑损伤潜在生物标志物的发展,以提高诊断能力.
- 探索急性脑损伤的各种生物标志物的诊断潜力.
主要方法:
- 搜索了PubMed关于脑损伤生物标志物的诊断潜力的研究.
- 访问了ClinicalTrials.gov以确定涉及生物标志物测量用于脑损伤诊断的临床试验.
主要成果:
- 确定了41种蛋白质,酶和激素作为潜在的脑损伤生物标志物.
- 其中20种生物标志物已在临床试验中进行了研究.
- 几种微RNA也显示出作为早期诊断生物标志物的前景.
结论:
- 循环生物标志物可以帮助治疗急性脑损伤并降低死亡率.
- 在一个面板中,多个生物标志物的组合,以及其他参数,显示出有希望的诊断结果.
- 对生物标志物面板的进一步研究可能会彻底改变对脑损伤的早期诊断.
更多相关视频
05:52Early Pathological and Magnetic Resonance Detection of Cerebral Injury Using a Rat Model of Neonatal Hypoxic Ischemic Encephalopathy
Published on: October 28, 2022
763
09:48Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice
Published on: May 4, 2015
13.8K
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
134
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
134
01:26Alzheimer's Disease: Overview
461
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
461